Celldex Therapeutics, Inc.
(NASDAQ : CLDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.38%183.681.1%$863.43m
GILDGilead Sciences, Inc.
-0.27%80.720.9%$828.00m
CELGCelgene Corporation
1.02%94.811.2%$768.67m
JUNOJuno Therapeutics, Inc.
1.96%86.6513.5%$580.24m
BIIBBiogen Inc.
0.48%288.831.2%$512.39m
REGNRegeneron Pharmaceuticals, Inc.
-1.09%319.522.7%$396.38m
VRTXVertex Pharmaceuticals Incorporated
-1.67%158.301.9%$353.37m
ALXNAlexion Pharmaceuticals, Inc.
-0.45%118.312.0%$255.45m
NKTRNektar Therapeutics
1.37%84.606.0%$250.46m
ILMNIllumina, Inc.
0.01%226.583.5%$230.72m
BLUEBluebird Bio, Inc.
2.00%209.5516.1%$195.78m
AAgilent Technologies, Inc.
1.41%72.081.5%$178.08m
INCYIncyte Corporation
0.51%85.952.5%$154.91m
BMRNBioMarin Pharmaceutical Inc.
1.01%84.704.4%$122.41m
EXASExact Sciences Corporation
-0.32%47.8626.0%$117.80m

Company Profile

Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.